Mouse anti Pig CD45RC
Products Name
Mouse anti Pig CD45RC
Cat.No.
PCMA0079
Size
Qty
Add to Cart
Inquiry
Overview
Description:
Mouse anti pig CD45RC, clone 3a56 recognizes a restricted CD45 epitope encoded by the CD45 C exon and will detect the ~210 kDa RC isoform.
CD45 in pigs has three cell surface expressed isoforms: CD45R, CD45RA, and CD45RC. CD45RC is mainly expressed by CD4+ T cells and weakly by B cells. However, during the immune response expression of CD45RC was found to decrease in activated T-helper cells. In contrast, increased expression of CD45RC was observed during the maturation of CD4- gamma delta thymocytes.
CD45 in pigs has three cell surface expressed isoforms: CD45R, CD45RA, and CD45RC. CD45RC is mainly expressed by CD4+ T cells and weakly by B cells. However, during the immune response expression of CD45RC was found to decrease in activated T-helper cells. In contrast, increased expression of CD45RC was observed during the maturation of CD4- gamma delta thymocytes.
Product Type:
Monoclonal antibody
Clone:
3a56
Isotype:
IgG1
Specificity:
CD45RC
Target:
Pig
Product Form:
Purified IgG - liquid.
Preparation:
Purified IgG prepared by affinity chromatography on protein A from tissue culture supernatant.
Buffer :
Phosphate buffered saline.
Preservative Stabilisers:
0.09% Sodium azide (NaN3).
Carrier Free:
Yes.
Approx. Protein Concentrations:
IgG concentration 1.0 mg/ml.
Regulatory:
For research purposes only.
Guarantee:
12 months from date of despatch.
Application:
Flow cytometry: use 10 µl of the suggested working dilution to label 106 cells in 100 µl.
Storage:
This product is shipped at ambient temperature. It is recommended to aliquot and store at -20°C on receipt. When thawed, aliquot the sample as needed. Keep aliquots at 2-8°C for short term use (up to 4 weeks) and store the remaining aliquots at -20°C.
Note:
Avoid repeated freezing and thawing as this may denature the antibody. Storage in frost-free freezers is not recommended. This product is photosensitive and should be protected from light.
